Evidence map›Paper›PMID 31900899›Full record

ArticleNeurotoxicity research2020

The Dephosphorylation of p70S6 (Thr

Anna Rorbach-Dolata, Anna Kicinska, Agnieszka Piwowar

Abstract read
PubMed Publisher
In one paragraph

Article in Neurotoxicity research, 2020. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 2 papers.

0numbers the graph read from it
0cells of the map it votes in
2citing papers in PubMed
0.3field-weighted citation impact, top 48% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

2 citing papers in PubMed, 5 citations in OpenAlex.

  1. Review
  2. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

3 authors at 2 institutions in 2 countries.

Anna Rorbach-DolataDepartment of Toxicology, Faculty of Pharmacy, Wroclaw Medical University, Borowska 211 Str., 50-556, Wroclaw, Poland. anna.rorbach-dolata@umed.wroc.pl.ORCID https://orcid.org/0000-0001-7509-6957
Anna KicinskaSchool of Biomedical and Healthcare Sciences, Plymouth University Peninsula Schools of Medicine and Dentistry, Plymouth University, Plymouth, UK.
Agnieszka PiwowarDepartment of Toxicology, Faculty of Pharmacy, Wroclaw Medical University, Borowska 211 Str., 50-556, Wroclaw, Poland.
Wroclaw Medical University · PLUniversity of Plymouth · GB

Funding

Uniwersytet Medyczny im. Piastów Slaskich we Wroclawiu STM.D150.17.063
6 · The paper itself

Abstract

Excitotoxicity is a modern clinical condition included in the pathogenesis of Alzheimer's disease. It is connected with diabetic disturbance, and it is still being analyzed in the context of the participation of the PI3K/mTOR pathway. A very important protein belonging to this pathway is p70S6K, whose activation promotes the pathogenesis of type 2 diabetes by the induction of insulin resistance. The study model was based on a PC12 cell line, derived from the pheochromocytoma of a rat adrenal medulla, cultured in RPMI 1640. The three reagents were used in different concentrations to create the model of excitotoxicity related to diabetes disturbances: L-glutamate (2.5 mM; 10 mM), glucose (150 mM; 200 mM), and insulin (0.093 mM; 0.371 mM). The aim of our study was to examine and evaluate the levels of phosphorylation of proteins involved in signal transduction controlled by MAPK, PI3K/Akt, and mTOR signaling pathways in L-glutamate-induced excitotoxicity with comorbid hyperglycemia and hyperinsulinemia imitating diabetic disturbances in in vitro conditions on PC12 cells. The results we obtained demonstrated the increased phosphorylation of p70S6K in Thr

Indexed as

AnimalsCell SurvivalDiabetes MellitusDisease Models, AnimalGlutamic AcidPC12 CellsPhosphorylationRatsRibosomal Protein S6 Kinases, 70-kDaSignal TransductionGlutamic AcidRibosomal Protein S6 Kinases, 70-kDaDephosphorylationDiabetesExcitotoxicityp70 ribosomal protein S6 kinasep70S6Kβ-Catenin

Identifiers

PMID31900899
OpenAlexW2998038712

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.